ArticleDrug design, development and therapy2019

Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.

Cuiling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.